A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes.
第一作者:
Sara,Mongiorgi
第一单位:
Cellular Signalling Laboratory, Department of Biomedical and Neuromotor Sciences, University of Bologna, Via Irnerio 48, 40126, Bologna, Italy.
作者:
医学主题词
人类(Humans);阿扎胞苷(Azacitidine);微RNAs(MicroRNAs);DNA甲基化(DNA Methylation);骨髓增生异常综合征(Myelodysplastic Syndromes);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);原癌基因蛋白质c-bcl-2(Proto-Oncogene Proteins c-bcl-2)
DOI
10.1186/s13148-023-01441-9
PMID
36803590
发布时间
2023-03-20
- 浏览1
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



